Immediate Impact

3 from Science/Nature 64 standout
Sub-graph 1 of 24

Citing Papers

The NLR family of innate immune and cell death sensors
2024 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
2 intermediate papers

Works of David Floch being referenced

Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high‐affinity anti‐IgE antibody, in atopic subjects
2014
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
2012

Author Peers

Author Last Decade Papers Cites
David Floch 62 111 115 136 122 5 402
R.N. Poston 44 75 54 116 109 7 358
Margaret C. Jost 40 38 41 208 68 6 372
Ashley M. Mahler 28 30 109 142 86 8 374
Barbara Reich 34 47 99 213 39 9 450
Ian Gotis‐Graham 19 153 50 172 67 10 439
Jan-Willem Cohen Tervaert 10 102 132 170 80 8 442
Clarissa J. Watts 57 115 115 127 72 7 378
Keying Ma 99 146 87 150 64 10 388
Brandt Levitt 67 101 142 274 18 6 447
Zsuzsanna Baka 19 157 139 91 35 8 398

All Works

Loading papers...

Rankless by CCL
2026